IBD MD at University of Colorado. Clinician and researcher. Tweets my own. Retweet not endorsement.
Joined May 2018
- Tweets523
- Following256
- Followers1.4K
- Likes868
Ben Click retweeted
Maybe time to just get the C diff test?
The first RCT of GI-PCR for acute diarrhea
👎more antibiotic use in PCR arm
👉no difference in any outcome
🤷♂️less time in isolation for PCR arm
This test is 💩, friends
Instead:
Supportive care
Test sparingly
Mostly cdiff
thelancet.com/action/showPdf…
Ben Click retweeted
🚨AGA New Guideline Alert🚨
🔗gastrojournal.org/article/S0…
▶️AGA Living Guideline: Pharmacological Management of Moderate-Severe Ulcerative Colitis
I’ll break down its 14 recommendations down over the next 7 tweets 🧵 👇
#AGA #GI #UC #IBD #MedTwitter
1/9
Ben Click retweeted
More RWE that combo-AT effective in refractory IBD (n=79) @jensemineriomd
🟢Mean Mayo 3▶️1
🟢Mean SES-CD 12▶️4
🟢73% clin improvement
🔴47% AEs (URIs and derm issues mostly)
bit.ly/4fm80WI
Ben Click retweeted
@ABennettMD did an amazing job at #ACG2024 presenting a multi-center study evaluating outcomes in transgender pts with IBD on gender affirming hormones!
@VUMCibd @VictorChedidMD @KiraNewmanMDPhD @JustinFieldMD @BenClickMD
Ben Click retweeted
🚨Fellows & jr attendings- Don't miss this on 9/18!
1⃣Find & negotiate your first or next GI/#IBD job, academic or community
2⃣Navigate career transitions or move to leadership
3⃣Q&A with those in the know
@drharrythomas @Marylandibddoc @JillGaidosMD @BenClickMD
Sign up 👇
Ben Click retweeted
It’s a packed 🏡 at #RMH2024! We are so thankful 🙌 for all of our amazing attendees and supporters for coming out bright ⭐️ and early 🌞on this Saturday!
Ben Click retweeted
Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. @MotherToBaby @JulsgaardMette @MLongMD link.springer.com/article/10…
Ben Click retweeted
It’s dope to scope! 🤣First year fellows start scoping right away on inpatient consult services and on outpatient endo blocks. Follow our fellows on instagram @colorado_gi #futureofgi #gifellowship #gifellows #gastroenterology #academicgi
Ben Click retweeted
#TaylorKarl with an outstanding presentation evaluating the cost-effectiveness of #calprotectin in post-op #CD monitoring. @BenClickMD @FrankIScottMD @IBDBen @DrJordanAxelrad @MRegueiroMD #DDW2024
Ben Click retweeted
Taylor Karl presenting our modeling data suggesting that fecal calprotectin monitoring reduces costs and improves quality of life in comparison to colonoscopic assessment in low risk post operative CD, supporting recently published guideline revisions @BenClickMD @CUGastroHep
Ben Click retweeted
POR in CD is biologically interesting. Endo and surgical POR @IBDBen @BenClickMD study @AGA_CGH
▶️biologics ⬇️🔦recurrence (across risk)
▶️biologics did not ⬇️✂️in low risk for POR
🟢total n good, so why? are we bad at risk stratifying POR?
cghjournal.org/article/S1542…
Ben Click retweeted
CD POR despite postop biologic prophylaxis?
Our study showed switching to a new biologic class leads to ⬇️ POR at next scope (aOR 0.26) and ⬆️ endoscopic healing (aOR 3.4) compared to therapy optimization! journals.lww.com/jcge/abstra…
@BenClickMD @IBDBen @EdBarnesMD @MRegueiroMD
Ben Click retweeted
Don't miss @FrankIScottMD speak on "AI in IBD" to learn better #patientcare strategies! Join us at #RMIBD2024 March 15-17. Register today at rockymountainibd.com #IBD #Gastroenterology #MedEd @Waseem_Ahmed @BenClickMD @IBDMD @MLongMD @mchiorean4
Ben Click retweeted
Join us in beautiful Sun Valley, Idaho March 15-17 for #RMIBD2024 with fantastic talks from @MLongMD @mchiorean4 @FrankIScottMD @BenClickMD & more. Now offering travel grants for interested GI fellows too! Register at: rockymountainibd.com/
Ben Click retweeted
Ecstatic “Matches” what we feel right now @CUDeptMedicine @CUAnschutz GI and Hepatology @liverazzi This crew is top-notch! 🔥🔥🌟🌟
Welcome to the CU GI Fam! – at Denver, CO
Everyone @CUAnschutz GI & Hepatology is ecstatic about our freshly matched Fellows! Congrats to all! Can’t wait to welcome y’all to the gang!
@ChidiEnunwa from Emory
@RachelHoffmanMD from Northwestern
Sarah Talamantes from Stanford
Corinne Camp & Bejan Saeedi from Colorado
Ben Click retweeted
#3 Retrospective study comparing UST to ADAL in post operative recurrence in CD. No difference in rates of post-op recurrence. In high risk patients is any biologic ok? @MRegueiroMD @MatthieuAllez
Ben Click retweeted
#2 SPICY RCT (got to love the name) Extensive mesenteric resection (compared to current mesenteric sparing surgery) for ileocecal CD did not improve rates of post-op recurrence. The end of further studies looking at the mesentery in POR CD? @MRegueiroMD @MatthieuAllez
Ben Click retweeted
SQ VDZ approved for UC by @US_FDA Sept 27, 2023
Data in @AGA_Gastro (VISIBLE1 Trial) 👇🏾
1. IV wk 0, 2 --> SQ EOW maintenance
2. IV maint. = SQ maint. for endpoints.
3. Check the diagram below the title. Done.
gastrojournal.org/article/S0…
Ben Click retweeted
📢 SEQUENCE: another head-to-head study in IBD ft. risankizumab vs ustekinumab in Crohn's disease and prior anti-TNF exposure. RISA was non-inferior for clinical remission and superior for endoscopic remission when compared to UST. Details ⬇️
prnewswire.com/news-releases…
Ben Click retweeted
🖨️📢 #Vedolizumab is comparable to #antiTNF tx in mgmt of steroid refractory #microscopic_colitis
@NabilElHageChe2 @DarrellPardi @FarrayeIBD @SGhoneimGI @jcg
Efficacy and Safety of Vedolizumab and Tumor Necrosis... : Journal of Clinical Gastroenterology journals.lww.com/jcge/abstra…